Regulate Gene Editing in Wild Animals
By Jeantine Lunshof,
Nature World View
| 05. 12. 2015
Gene editing is a hot topic following a flurry of interest in the use of CRISPR tools to modify human embryos. As an ethicist in a genome-engineering lab, I am an eyewitness to these recent scientific developments and I do have concerns about the way gene editing could be used. But they are not the concerns you might expect.
The ethical issues raised by human germline engineering are not new. They deserve consideration, but outcry over designer babies and precision gene therapy should not blind us to a much more pressing problem: the increasing use of CRISPR to edit the genomes of wild animal populations. Unless properly regulated and contained, this research has the potential to rapidly alter ecosystems in irreversible and damaging ways.
Scientists have already used CRISPR to modify mosquitoes and the fruit fly Drosophila melanogaster. And in combination with another molecular-biology technique called gene drive, they have found a way to massively increase the efficiency of spreading these transformations to offspring and through the population. Once introduced, these genetic changes are self-propagating. If released beyond the...
Related Articles
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Shayna Korol, Vox | 06.12.2026
AI company CEOs Sam Altman (OpenAI), Demis Hassabis (Google DeepMind), and Dario Amodei (Anthropic) disagree on a lot, like how fast the technology should develop, the best way to regulate it, and how to prepare society for smarter-than-human AI, among...